OVARIAN CLEAR CELL CYSTADENOCARCINOMA
Clinical trials for OVARIAN CLEAR CELL CYSTADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CYSTADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CYSTADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug metformin may boost chemo for ovarian cancer
Disease control CompletedThis phase II trial tested whether adding metformin, a common diabetes drug, to standard chemotherapy could help control advanced ovarian, fallopian tube, or primary peritoneal cancer. 111 participants received either metformin or a placebo alongside chemotherapy, followed by mai…
Matched conditions: OVARIAN CLEAR CELL CYSTADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a custom vaccine help fight ovarian cancer?
Disease control CompletedThis early-phase trial tested a personalized vaccine made from a patient's own immune cells to see if it is safe for people with advanced ovarian, fallopian tube, or peritoneal cancer. Nineteen participants who had already undergone surgery and chemotherapy received the vaccine. …
Matched conditions: OVARIAN CLEAR CELL CYSTADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC